Election backlash foreseeable over revision of pharmaceutical affairs law

Published: 2011-10-28 06:58:00

Updated: 2011-10-28 06:58:00

The Korean Pharmaceutical Association is afraid that the Grand National Party and Chong Wae Dae might crank up efforts to pass a bill from the National Assembly to make cold medicines and fever reducers available at supermarkets and convenience stores in the wake of Wednesday’s election victory o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK